HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Multi-Benefit Products, Nail Care Succeeding With Value Shoppers

This article was originally published in The Rose Sheet

Executive Summary

Value-oriented shoppers in the U.S. are fueling the development of personal-care products that deliver multiple benefits, according to worldwide research and consulting firm Kline & Company

You may also be interested in...



Designers, "Mad Men" Couldn't Help Lipstick In 2009 - Euromonitor Report

With lipstick sales down 8 percent in 2009, market analysts have witnessed the antithesis of the "lipstick effect.

Designers, "Mad Men" Couldn't Help Lipstick In 2009 - Euromonitor Report

With lipstick sales down 8 percent in 2009, market analysts have witnessed the antithesis of the "lipstick effect.

HSN Pulling Out All Stops For Carol's Daughter's First Celeb Fragrance

Interactive multichannel retailer HSN will launch My Life by Mary J. Blige this summer in collaboration with Carol's Daughter, setting a new standard for fragrance marketing, it says

Related Content

UsernamePublicRestriction

Register

RS016872

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel